PATCH Act
Summary
The PATCH Act, introduced May 21, 2026, would ban medical debt from consumer credit reports and prohibit creditors from using medical debt in lending decisions. This largely codifies existing CFPB rules and industry practices — major banks have already removed most medical debt from underwriting. No material financial impact on JPMorgan ($JPM), Bank of America ($BAC), Citigroup ($C), or Wells Fargo ($WFC) given it affects <0.1% of revenue.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Bill at early stage (referred to committee, no markup)
- 2.Codifies existing CFPB rules and industry practice — minimal new impact
- 3.Revenue impact on US banks ($JPM, $BAC, $C, $WFC) below 0.1% of total revenue
- 4.No direct winners or losers among publicly traded companies; neutral for financial sector
Market Implications
US banking stocks are unaffected by this bill. The legislation is procedurally weak — single sponsor, no companion bill, referred to committee with no further action. Market pricing of bank stocks already reflects the existing CFPB rule. No positioning required. For retail investors, this is a non-event. Focus on other congressional actions with real spending or regulatory teeth.
Full Analysis
This bill, S. 4622, the PATCH Act, was introduced by Sen. Kennedy (R-LA) on May 21, 2026, and referred to the Senate Banking Committee. It is in an early stage with no markup or vote scheduled. The bill amends the Fair Credit Reporting Act to exclude all 'medical debt' from consumer reports and requires the CFPB to revise Regulation B (Equal Credit Opportunity Act) to bar creditors from using medical debt in credit decisions. There is no authorized funding; this is a regulatory mandate on private companies. The CFPB already finalized a rule in January 2023 removing medical debt under $500 from credit reports, and in January 2025 proposed a broader rule targeting all medical debt. Most major lenders (JPM, BAC, C, WFC) already apply internal policies minimizing medical debt weighting. The incremental impact of this bill is therefore marginal — it would codify existing practices, potentially adding enforcement risk for noncompliance but not changing day-to-day operations. The only potential winners are consumers with outstanding medical debt, who may see slight credit score improvements. No publicly traded company stands to gain or lose significant revenue. Collections agencies and credit bureaus (Equifax, Experian, TransUnion — private or foreign-listed) could see negligible data processing changes. Among major US banks, the affected revenue is below 0.1% of total, making this a neutral event for investors. Timeline: remains in committee; companion bill in House not yet introduced. Passage probability before the 2026 midterms is low given early stage and lack of bipartisan co-sponsors.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Same prohibition on medical debt in credit reports and creditor use.
Who must act
Creditors and credit reporting agencies.
What happens
Bank of America's consumer banking segment (cards, home loans, auto) must update underwriting models; a CFPB rule finalized in 2023 already removed medical debt under $500 from credit reports, and major lenders already discount medical debt, so this largely codifies existing practice.
Stock impact
BAC's consumer banking revenue is ~$35B of total $102.8B revenue; medical debt exclusion has minimal incremental impact beyond current CFPB rule. No material revenue effect.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
To amend title 11, United States Code, to provide bankruptcy protections for medically distressed debtors, and for other purposes.
GUIDANCE Act of 2026
Protecting Workers' Wages from Medical Debt Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →